While some research has shown benefits for patients who qualify, questions remain about the therapy's long-term risks and use among men without a medical need.

A recent retrospective study published in the Indian Journal of Nephrology in February 2026 reveals that 60.79% of diabetic ...

Dr. David Eisenman and Kirsten Schwarz, both professors at the UCLA Fielding School of Public Health, study the public health ...

With War Secretary Pete Hegseth fueling a national conversation about testosterone, many men may wonder whether their own ...

People who have poor metabolic health are also more likely to live with obesity, which raises the risk of several other ...

Scientists are exploring why high temperatures may increase brain stroke risk, who is most at risk, and how the threat may ...

Extreme heat could be costing Indian workers the equivalent of 2% of their country’s GDP every year, according to new IIED ...

CareDx has a transplant-testing franchise that taps into recurring surveillance demand and has deeper integration into ...

Bristol Myers is the third pharmaceutical company to recently seek Nvidia’s help building a large AI data center. Elsewhere, a Novartis kidney drug gained a leg up on competitors.

BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic ...

Jim Owen went from being a physical wreck to a gold medalist after age 70. Learn how walking, strength training, and making ...